United States Biotechnology & Medical Research

Replimune Group Inc (REPL)

Track

Track

Replimune Group Inc. executives recently executed multiple stock sales totaling over one million dollars. These transactions occurred following the company's latest results financiers, amid a significant ninety-day share price appreciation of 70.5%. Key leadership, including the CEO and CFO, offloaded equity holdings as the stock traded near its annual peak.
Ticker: REPL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Replimune Group Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
361.41
Quantity 60,555 -35.9%
Value US$4,707,823
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Sale
Price
91.68
Quantity 18,810 +26.5%
Value US$2,602,493
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
194.56
Quantity 17,995 +32.1%
Value US$1,159,937
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
12.97
Quantity 11,448 -4.8%
Value US$148,481
1.6
Schwendenman Andrew Chief Accounting Officer Officer
Transaction date
Sale
Price
12.97
Quantity 7,632 -7.1%
Value US$98,987
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Planned sale
Price
9.24
Quantity 12,000 -6.2%
Value US$110,880
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
5.08
Quantity 7,812 -3.2%
Value US$39,685
1.6
Schwendenman Andrew Chief Accounting Officer Officer
Transaction date
Sale
Price
5.08
Quantity 7,894 -6.9%
Value US$40,102
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Sale
Price
5.08
Quantity 37,324 -4.8%
Value US$189,606
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
5.08
Quantity 8,626 -4.3%
Value US$43,820
2.1
Astley-Sparke Philip Non-Executive Director
Transaction date
Sale
Price
5.08
Quantity 17,657 -1.2%
Value US$89,698
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
5.08
Quantity 14,023 -5.6%
Value US$71,237
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Planned sale
Price
8.01
Quantity 6,500 -4.1%
Value US$52,065
2.5
Christopher Sarchi Officer Officer
Transaction date
Proposed sale
Price
7.70
Quantity 18,500
Value US$142,450
3.5
Dhingra Kapil Non-Executive Director
Transaction date
Sale
Price
10.40
Quantity 3,169 -100.0%
Value US$32,958
3.5
Kapil Dhingra Director Non-Executive Director
Transaction date
Proposed sale
Price
10.38
Quantity 3,164
Value US$32,842
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
11.13
Quantity 10,000 -2.9%
Value US$111,300
1.8
Sushil Patel Chief Strategy Officer Officer
Transaction date
Proposed sale
Price
11.13
Quantity 10,000
Value US$111,303
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
9.10
Quantity 7,248 -4.9%
Value US$65,957
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
9.10
Quantity 5,208 -4.1%
Value US$47,393
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
5.37
Quantity 9,154 -6.4%
Value US$49,157
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
8.05
Quantity 3,749 -2.8%
Value US$30,179
1.6
Schwendenman Andrew Chief Accounting Officer Officer
Transaction date
Sale
Price
8.05
Quantity 3,287 -4.6%
Value US$26,460
2.1
Astley-Sparke Philip Non-Executive Director
Transaction date
Sale
Price
8.06
Quantity 32,279 -2.2%
Value US$260,169
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
8.06
Quantity 7,952 -5.1%
Value US$64,093
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
8.05
Quantity 2,535 -1.7%
Value US$20,407
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Sale
Price
8.06
Quantity 25,105 -6.8%
Value US$202,346
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.42
Quantity 10,000 -4.7%
Value US$124,200
1.8
Sushil Patel Chief Strategy Officer Officer
Transaction date
Proposed sale
Price
12.57
Quantity 15,000
Value US$188,550
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
10.78
Quantity 7,246 -6.2%
Value US$78,112
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
10.78
Quantity 5,207 -5.6%
Value US$56,131
2.4
Hill Emily Luisa Chief Financial Officer Officer
Transaction date
Sale
Price
10.18
Quantity 8,938 -8.1%
Value US$90,989
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.50
Quantity 15,881 -11.9%
Value US$119,108
2.6
Konstantinos Xynos Officer Officer
Transaction date
Proposed sale
Price
7.50
Quantity 15,881
Value US$119,185
1.2
Pamela Esposito Officer Officer
Transaction date
Proposed sale
Price
5.93
Quantity 79,710
Value US$472,680
1.4
Coffin Robert Non-Executive Director
Transaction date
Sale
Price
6.47
Quantity 11,464 -0.6%
Value US$74,172
1.4
Love Colin Chief Operating Officer Officer
Transaction date
Sale
Price
6.47
Quantity 17,615 -2.2%
Value US$113,969
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.47
Quantity 20,194 -8.7%
Value US$130,655
1.8
Patel Sushil Chief Executive Officer Executive Director
Transaction date
Sale
Price
6.47
Quantity 20,194 -8.7%
Value US$130,655
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
6.47
Quantity 2,218 -2.3%
Value US$14,350
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
6.47
Quantity 2,218 -2.3%
Value US$14,350
1.6
Schwendenman Andrew Chief Accounting Officer Officer
Transaction date
Sale
Price
6.47
Quantity 2,298 -5.7%
Value US$14,868
1.6
Schwendenman Andrew Chief Accounting Officer Officer
Transaction date
Sale
Price
6.47
Quantity 2,298 -5.7%
Value US$14,868
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
6.47
Quantity 6,367 -4.6%
Value US$41,194
2.1
Astley-Sparke Philip Executive Chairman Executive Director
Transaction date
Sale
Price
6.47
Quantity 37,928 -2.5%
Value US$245,394
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
10.92
Quantity 7,313 -6.1%
Value US$79,858
2.5
Sarchi Christopher Chief Commercial Officer Officer
Transaction date
Sale
Price
10.92
Quantity 5,255 -6.8%
Value US$57,385
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 300 -0.1%
Value US$6,000
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
20.01
Quantity 5,358 -2.0%
Value US$107,214
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
20.01
Quantity 18,600 -6.6%
Value US$372,186
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 1,400 -0.5%
Value US$28,000
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
21.12
Quantity 2,077 -0.8%
Value US$43,866
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
21.63
Quantity 17,923 -6.3%
Value US$387,674
1.2
Pamela Esposito Officer Officer
Transaction date
Proposed sale
Price
21.18
Quantity 80,000
Value US$1,694,400
2.0
Lewis Tanya Chief Dev. Op. Officer Officer
Transaction date
Planned sale
Price
23.45
Quantity 817 -0.6%
Value US$19,159
2.0
Lewis Tanya Chief Dev. Op. Officer Officer
Transaction date
Planned sale
Price
24.10
Quantity 12,043 -8.1%
Value US$290,236
1.8
Patel Sushil Chief Strategy Officer Officer
Transaction date
Planned sale
Price
23.44
Quantity 553 -0.4%
Value US$12,962
1.8
Patel Sushil Chief Strategy Officer Officer
Transaction date
Planned sale
Price
24.11
Quantity 5,145 -3.3%
Value US$124,046
2.0
Tanya Lewis Affiliate
Transaction date
Proposed sale
Price
23.45
Quantity 22,486
Value US$527,297
1.8
Sushil Patel Affiliate
Transaction date
Proposed sale
Price
23.45
Quantity 23,710
Value US$555,999
1.4
Coffin Robert President & Chief R&D Officer Executive Director
Transaction date
Sale
Price
18.05
Quantity 7,861 -0.4%
Value US$141,891
1.4
Love Colin Chief Operating Officer Officer
Transaction date
Sale
Price
18.05
Quantity 10,775 -1.3%
Value US$194,489
2.6
Xynos Konstantinos Chief Medical Officer Officer
Transaction date
Sale
Price
18.05
Quantity 771 -0.6%
Value US$13,917
1.8
Patel Sushil Chief Strategy Officer Officer
Transaction date
Sale
Price
18.05
Quantity 15,575 -9.2%
Value US$281,129
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Sale
Price
18.05
Quantity 5,966 -2.2%
Value US$107,686
2.4
Franchi Jean M. Chief Financial Officer Officer
Transaction date
Sale
Price
18.05
Quantity 11,351 -8.1%
Value US$204,886
2.1
Astley-Sparke Philip Chief Executive Officer Executive Director
Transaction date
Sale
Price
18.05
Quantity 17,902 -1.2%
Value US$323,131
2.0
Lewis Tanya Chief Dev. Op. Officer Officer
Transaction date
Sale
Price
18.05
Quantity 12,207 -7.6%
Value US$220,336
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Planned sale
Price
25.03
Quantity 15,000 -6.1%
Value US$375,450
1.4
Coffin Robert President & Chief R&D Officer Executive Director
Transaction date
Sale
Price
14.59
Quantity 5,737 -0.3%
Value US$83,703
1.4
Love Colin Chief Operating Officer Officer
Transaction date
Sale
Price
14.59
Quantity 6,324 -0.8%
Value US$92,267
1.8
Patel Sushil Chief Commercial Officer Officer
Transaction date
Sale
Price
14.59
Quantity 10,687 -7.6%
Value US$155,923
2.1
Astley-Sparke Philip Chief Executive Officer Executive Director
Transaction date
Sale
Price
14.59
Quantity 9,632 -0.7%
Value US$140,531
1.2
Esposito Pamela Chief Business Officer Officer
Transaction date
Sale
Price
14.59
Quantity 3,507 -1.5%
Value US$51,167
2.0
Lewis Tanya Chief Dev. Op Officer Officer
Transaction date
Sale
Price
14.59
Quantity 5,473 -4.3%
Value US$79,851
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-17 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
60,555 -35.9%
361.41
US$4,707,823 		60,555 -35.9% 361.41 US$4,707,823
2026-08-12 2026-08-10 S Sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
18,810 +26.5%
91.68
US$2,602,493 		18,810 +26.5% 91.68 US$2,602,493
2026-08-12 2026-08-10 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
17,995 +32.1%
194.56
US$1,159,937 		17,995 +32.1% 194.56 US$1,159,937
2026-08-12 2026-08-10 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
11,448 -4.8%
12.97
US$148,481 		11,448 -4.8% 12.97 US$148,481
2026-08-12 2026-08-10 S Sale
1.6
Schwendenman Andrew

Chief Accounting Officer

Officer
7,632 -7.1%
12.97
US$98,987 		7,632 -7.1% 12.97 US$98,987
2026-06-03 2026-06-01 PlS Planned sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
12,000 -6.2%
9.24
US$110,880 		12,000 -6.2% 9.24 US$110,880
2026-05-20 2026-05-18 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
7,812 -3.2%
5.08
US$39,685 		7,812 -3.2% 5.08 US$39,685
2026-05-20 2026-05-18 S Sale
1.6
Schwendenman Andrew

Chief Accounting Officer

Officer
7,894 -6.9%
5.08
US$40,102 		7,894 -6.9% 5.08 US$40,102
2026-05-20 2026-05-18 S Sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
37,324 -4.8%
5.08
US$189,606 		37,324 -4.8% 5.08 US$189,606
2026-05-20 2026-05-18 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
8,626 -4.3%
5.08
US$43,820 		8,626 -4.3% 5.08 US$43,820
2026-05-20 2026-05-18 S Sale
2.1
Astley-Sparke Philip
Non-Executive Director
17,657 -1.2%
5.08
US$89,698 		17,657 -1.2% 5.08 US$89,698
2026-05-20 2026-05-18 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
14,023 -5.6%
5.08
US$71,237 		14,023 -5.6% 5.08 US$71,237
2026-04-06 2026-04-02 PlS Planned sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
6,500 -4.1%
8.01
US$52,065 		6,500 -4.1% 8.01 US$52,065
2026-04-02 2026-04-02 PrS Proposed sale
2.5
Christopher Sarchi

Officer

Officer
18,500
7.70
US$142,450 		18,500 7.70 US$142,450
2025-12-11 2025-12-09 S Sale
3.5
Dhingra Kapil
Non-Executive Director
3,169 -100.0%
10.40
US$32,958 		3,169 -100.0% 10.40 US$32,958
2025-12-09 2025-12-09 PrS Proposed sale
3.5
Kapil Dhingra

Director

Non-Executive Director
3,164
10.38
US$32,842 		3,164 10.38 US$32,842
2025-12-04 2025-12-02 PlS Planned sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
10,000 -2.9%
11.13
US$111,300 		10,000 -2.9% 11.13 US$111,300
2025-12-02 2025-12-02 PrS Proposed sale
1.8
Sushil Patel

Chief Strategy Officer

Officer
10,000
11.13
US$111,303 		10,000 11.13 US$111,303
2025-11-19 2025-11-17 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
7,248 -4.9%
9.10
US$65,957 		7,248 -4.9% 9.10 US$65,957
2025-11-19 2025-11-17 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
5,208 -4.1%
9.10
US$47,393 		5,208 -4.1% 9.10 US$47,393
2025-08-19 2025-08-15 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
9,154 -6.4%
5.37
US$49,157 		9,154 -6.4% 5.37 US$49,157
2025-05-22 2025-05-20 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
3,749 -2.8%
8.05
US$30,179 		3,749 -2.8% 8.05 US$30,179
2025-05-22 2025-05-20 S Sale
1.6
Schwendenman Andrew

Chief Accounting Officer

Officer
3,287 -4.6%
8.05
US$26,460 		3,287 -4.6% 8.05 US$26,460
2025-05-22 2025-05-20 S Sale
2.1
Astley-Sparke Philip
Non-Executive Director
32,279 -2.2%
8.06
US$260,169 		32,279 -2.2% 8.06 US$260,169
2025-05-22 2025-05-20 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
7,952 -5.1%
8.06
US$64,093 		7,952 -5.1% 8.06 US$64,093
2025-05-22 2025-05-20 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
2,535 -1.7%
8.05
US$20,407 		2,535 -1.7% 8.05 US$20,407
2025-05-22 2025-05-20 S Sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
25,105 -6.8%
8.06
US$202,346 		25,105 -6.8% 8.06 US$202,346
2024-12-18 2024-12-16 PlS Planned sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
10,000 -4.7%
12.42
US$124,200 		10,000 -4.7% 12.42 US$124,200
2024-12-16 2024-12-16 PrS Proposed sale
1.8
Sushil Patel

Chief Strategy Officer

Officer
15,000
12.57
US$188,550 		15,000 12.57 US$188,550
2024-11-20 2024-11-18 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
7,246 -6.2%
10.78
US$78,112 		7,246 -6.2% 10.78 US$78,112
2024-11-20 2024-11-18 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
5,207 -5.6%
10.78
US$56,131 		5,207 -5.6% 10.78 US$56,131
2024-08-19 2024-08-16 S Sale
2.4
Hill Emily Luisa

Chief Financial Officer

Officer
8,938 -8.1%
10.18
US$90,989 		8,938 -8.1% 10.18 US$90,989
2024-06-10 2024-06-07 PlS Planned sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
15,881 -11.9%
7.50
US$119,108 		15,881 -11.9% 7.50 US$119,108
2024-06-07 2024-06-07 PrS Proposed sale
2.6
Konstantinos Xynos

Officer

Officer
15,881
7.50
US$119,185 		15,881 7.50 US$119,185
2024-05-23 2024-05-23 PrS Proposed sale
1.2
Pamela Esposito

Officer

Officer
79,710
5.93
US$472,680 		79,710 5.93 US$472,680
2024-05-20 2024-05-16 S Sale
1.4
Coffin Robert
Non-Executive Director
11,464 -0.6%
6.47
US$74,172 		11,464 -0.6% 6.47 US$74,172
2024-05-20 2024-05-16 S Sale
1.4
Love Colin

Chief Operating Officer

Officer
17,615 -2.2%
6.47
US$113,969 		17,615 -2.2% 6.47 US$113,969
2024-05-20 2024-05-16 S Sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
20,194 -8.7%
6.47
US$130,655 		20,194 -8.7% 6.47 US$130,655
2024-05-20 2024-05-16 S Sale
1.8
Patel Sushil

Chief Executive Officer

Executive Director
20,194 -8.7%
6.47
US$130,655 		20,194 -8.7% 6.47 US$130,655
2024-05-20 2024-05-16 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
2,218 -2.3%
6.47
US$14,350 		2,218 -2.3% 6.47 US$14,350
2024-05-20 2024-05-16 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
2,218 -2.3%
6.47
US$14,350 		2,218 -2.3% 6.47 US$14,350
2024-05-20 2024-05-16 S Sale
1.6
Schwendenman Andrew

Chief Accounting Officer

Officer
2,298 -5.7%
6.47
US$14,868 		2,298 -5.7% 6.47 US$14,868
2024-05-20 2024-05-16 S Sale
1.6
Schwendenman Andrew

Chief Accounting Officer

Officer
2,298 -5.7%
6.47
US$14,868 		2,298 -5.7% 6.47 US$14,868
2024-05-20 2024-05-16 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
6,367 -4.6%
6.47
US$41,194 		6,367 -4.6% 6.47 US$41,194
2024-05-20 2024-05-16 S Sale
2.1
Astley-Sparke Philip

Executive Chairman

Executive Director
37,928 -2.5%
6.47
US$245,394 		37,928 -2.5% 6.47 US$245,394
2023-11-17 2023-11-16 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
7,313 -6.1%
10.92
US$79,858 		7,313 -6.1% 10.92 US$79,858
2023-11-17 2023-11-16 S Sale
2.5
Sarchi Christopher

Chief Commercial Officer

Officer
5,255 -6.8%
10.92
US$57,385 		5,255 -6.8% 10.92 US$57,385
2023-09-13 2023-09-12 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
300 -0.1%
20.00
US$6,000 		300 -0.1% 20.00 US$6,000
2023-09-13 2023-09-11 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
5,358 -2.0%
20.01
US$107,214 		5,358 -2.0% 20.01 US$107,214
2023-08-24 2023-08-22 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
18,600 -6.6%
20.01
US$372,186 		18,600 -6.6% 20.01 US$372,186
2023-08-15 2023-08-11 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
1,400 -0.5%
20.00
US$28,000 		1,400 -0.5% 20.00 US$28,000
2023-07-11 2023-07-10 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
2,077 -0.8%
21.12
US$43,866 		2,077 -0.8% 21.12 US$43,866
2023-07-11 2023-07-10 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
17,923 -6.3%
21.63
US$387,674 		17,923 -6.3% 21.63 US$387,674
2023-07-10 2023-07-10 PrS Proposed sale
1.2
Pamela Esposito

Officer

Officer
80,000
21.18
US$1,694,400 		80,000 21.18 US$1,694,400
2023-06-15 2023-06-13 PlS Planned sale
2.0
Lewis Tanya

Chief Dev. Op. Officer

Officer
817 -0.6%
23.45
US$19,159 		817 -0.6% 23.45 US$19,159
2023-06-15 2023-06-13 PlS Planned sale
2.0
Lewis Tanya

Chief Dev. Op. Officer

Officer
12,043 -8.1%
24.10
US$290,236 		12,043 -8.1% 24.10 US$290,236
2023-06-15 2023-06-13 PlS Planned sale
1.8
Patel Sushil

Chief Strategy Officer

Officer
553 -0.4%
23.44
US$12,962 		553 -0.4% 23.44 US$12,962
2023-06-15 2023-06-13 PlS Planned sale
1.8
Patel Sushil

Chief Strategy Officer

Officer
5,145 -3.3%
24.11
US$124,046 		5,145 -3.3% 24.11 US$124,046
2023-06-13 2023-06-13 PrS Proposed sale
2.0
Tanya Lewis

Affiliate
22,486
23.45
US$527,297 		22,486 23.45 US$527,297
2023-06-13 2023-06-13 PrS Proposed sale
1.8
Sushil Patel

Affiliate
23,710
23.45
US$555,999 		23,710 23.45 US$555,999
2023-05-18 2023-05-16 S Sale
1.4
Coffin Robert

President & Chief R&D Officer

Executive Director
7,861 -0.4%
18.05
US$141,891 		7,861 -0.4% 18.05 US$141,891
2023-05-18 2023-05-16 S Sale
1.4
Love Colin

Chief Operating Officer

Officer
10,775 -1.3%
18.05
US$194,489 		10,775 -1.3% 18.05 US$194,489
2023-05-18 2023-05-16 S Sale
2.6
Xynos Konstantinos

Chief Medical Officer

Officer
771 -0.6%
18.05
US$13,917 		771 -0.6% 18.05 US$13,917
2023-05-18 2023-05-16 S Sale
1.8
Patel Sushil

Chief Strategy Officer

Officer
15,575 -9.2%
18.05
US$281,129 		15,575 -9.2% 18.05 US$281,129
2023-05-18 2023-05-16 S Sale
1.2
Esposito Pamela

Chief Business Officer

Officer
5,966 -2.2%
18.05
US$107,686 		5,966 -2.2% 18.05 US$107,686
2023-05-18 2023-05-16 S Sale
2.4
Franchi Jean M.

Chief Financial Officer

Officer
11,351 -8.1%
18.05
US$204,886 		11,351 -8.1% 18.05 US$204,886
2023-05-18 2023-05-16 S Sale
2.1
Astley-Sparke Philip

Chief Executive Officer

Executive Director
17,902 -1.2%
18.05
US$323,131 		17,902 -1.2% 18.05 US$323,131
2023-05-18 2023-05-16 S Sale
2.0
Lewis Tanya

Chief Dev. Op. Officer

Officer
12,207 -7.6%
18.05
US$220,336 		12,207 -7.6% 18.05 US$220,336
2022-12-13 2022-12-09 PlS Planned sale
1.2
Esposito Pamela

Chief Business Officer

Officer
15,000 -6.1%
25.03
US$375,450 		15,000 -6.1% 25.03 US$375,450
2022-05-18 2022-05-16 S Sale
1.4
Coffin Robert

President & Chief R&D Officer

Executive Director
5,737 -0.3%
14.59
US$83,703 		5,737 -0.3% 14.59 US$83,703
2022-05-18 2022-05-16 S Sale
1.4
Love Colin

Chief Operating Officer

Officer
6,324 -0.8%
14.59
US$92,267 		6,324 -0.8% 14.59 US$92,267
2022-05-18 2022-05-16 S Sale
1.8
Patel Sushil

Chief Commercial Officer

Officer
10,687 -7.6%
14.59
US$155,923 		10,687 -7.6% 14.59 US$155,923
2022-05-18 2022-05-16 S Sale
2.1
Astley-Sparke Philip

Chief Executive Officer

Executive Director
9,632 -0.7%
14.59
US$140,531 		9,632 -0.7% 14.59 US$140,531
2022-05-18 2022-05-16 S Sale
1.2
Esposito Pamela

Chief Business Officer

Officer
3,507 -1.5%
14.59
US$51,167 		3,507 -1.5% 14.59 US$51,167
2022-05-18 2022-05-16 S Sale
2.0
Lewis Tanya

Chief Dev. Op Officer

Officer
5,473 -4.3%
14.59
US$79,851 		5,473 -4.3% 14.59 US$79,851
Explore more

More insider trading research around Replimune Group Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America